Citation Impact
Citing Papers
AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan
2011 Standout
Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome
2018 Standout
The effects of oxidative stress on female reproduction: a review
2012 Standout
d-Galactose-induced accelerated aging model: an overview
2019 Standout
Follicle dynamics and anovulation in polycystic ovary syndrome
2008
Comparison of serum anti-Müllerian hormone levels in normal weight and overweight–obese adolescent patients with polycystic ovary syndrome
2014
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
2014
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
2011 Standout
Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
2012
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)
2010
Pathophysiology of Polycystic Ovary Syndrome: The Role of Hyperandrogenism
2012
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Anti-Müllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels
2008
Is polycystic ovary syndrome an exception for reproductive aging?
2010
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
Fertility and infertility: Definition and epidemiology
2018 Standout
Is foetal hyperexposure to androgens a cause of PCOS?
2017
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
2011
Executive summary of the Stages of Reproductive Aging Workshop + 10
2012 Standout
Polycystic ovary syndrome (PCOS)-like phenotypes in the d-galactose-induced aging mouse model
2012
Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro
2008
Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features
2012
Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?
2016
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Nonhuman primate models of polycystic ovary syndrome
2013
Anti-Mullerian hormone (AMH): what do we still need to know?
2009
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
2009
Polycystic ovary syndrome
2016 Standout
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
2011 Standout
Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries
2012
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Anti-Müllerian hormone and ovarian dysfunction
2008
Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury
2008
PCOS Forum: research in polycystic ovary syndrome today and tomorrow
2010
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society
2013
Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.
1976 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Anti-MüLlerian Hormone as a Marker of Ovarian Reserve: An Update
2008
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Role of Oxidative Stress in Polycystic Ovary Syndrome
2010
Variations in the Pattern of Pubertal Changes in Boys
1970 Standout
State-of-the-science of endocrine disrupting chemicals, 2012
2012
Interrelationships between Ovarian and Pituitary Hormones in Ovulatory Menstrual Cycles across Reproductive Age
2008
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
2015
Circulating AMH Reflects Ovarian Morphology by Magnetic Resonance Imaging and 3D Ultrasound in 121 Healthy Girls
2014
The Halogen Bond
2016 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Physiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics
2016
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
2016
Works of Laura Pellatt being referenced
Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?
2010
Granulosa Cell Production of Anti-Müllerian Hormone Is Increased in Polycystic Ovaries
2006
Ovarian 11β-Hydroxysteroid Dehydrogenase (11βHSD) Activity Is Suppressed in Women With Anovulatory Polycystic Ovary Syndrome (PCOS): Apparent Role for Ovarian Androgens
2013
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review
2008
Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells
2011
Pharmacological activators of AMP‐activated protein kinase have different effects on Na+ transport processes across human lung epithelial cells
2007
Metformin Inhibits Follicle-Stimulating Hormone (FSH) Action in Human Granulosa Cells: Relevance to Polycystic Ovary Syndrome
2013
Metformin Inhibits Aromatase via an Extracellular Signal-Regulated Kinase-Mediated Pathway
2009